Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Clinterooon Aug 21, 2013 9:11am

74 Views

Post# 21685840

RE:RE:RE:RE:RE:Dumb & Dumber!!!

He is considered an insider because he owns more than 5% of the shares.

We shall see what impact, if any, this has.

The bad thing is that this guy had 6,000,000 shares so he still has 4,000,000. Hopefully he sold the 2 million to get some money back and is going to hold the other 4 million for a longer period.

He also has 6 million warrants which gives him an option to buy at $0.15. Not sure if we want him exercising those.

Bullboard Posts

Three business reasons companies need to recycle e-waste